Skip to main content
Clinical Trials/ISRCTN37551129
ISRCTN37551129
Active, not recruiting
未知

A study of DNA methylation of bladder cancer markers in urine and bladder tissue of patients with neurogenic lower urinary tract dysfunction

Aristotle University of Thessaloniki0 sites70 target enrollmentJune 14, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Aristotle University of Thessaloniki
Enrollment
70
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2023
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Neurogenic lower urinary tract dysfunction group:
  • 1\. Neurogenic lower urinary tract dysfunction duration for at least 5 years scheduled for cystoscopy, wash cytology and bladder biopsy
  • 2\. Age 18 years or older
  • 3\. Consent to provide urine sample and bladder tissue
  • Control group (healthy volunteers):
  • 1\. Age 18 years or older
  • 2\. Consent to provide urine sample

Exclusion Criteria

  • Neurogenic lower urinary tract dysfunction group:
  • 1\. Prior diagnosis and treatment of bladder cancer
  • 2\. History of other urinary tract malignancy
  • Control group (healthy volunteers):
  • 1\. Lower urinary tract symptoms
  • 2\. History of urinary tract malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials